Market Overview:
The global in vitro diagnostics (IVD) quality control market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for quality controls, data management, and quality assurance services across different applications such as clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation, microbiology and others. Additionally, the rising prevalence of chronic diseases and technological advancements are also contributing to the growth of this market. However; stringent regulatory requirements may restrain the growth of this market during the forecast period. On the basis of type, quality controls accounted for majority share in 2017 and is expected to maintain its dominance during forecast period owing to its wide applicability in different IVD assays. Data management is projected to be fastest growing segment due its ability manage voluminous data generated by various diagnostic tests thereby aiding efficient decision making process within laboratories. On basis on application; clinical chemistry held largest share in 2017 followed by immunochemistry owing high adoption rates for these tests across hospitals & clinics worldwide .
Product Definition:
IVD quality control (QC) is the process of ensuring that in vitro diagnostic tests and their results meet predetermined quality criteria. The purpose of IVD QC is to protect patient safety by detecting and preventing the use of inaccurate or improperly functioning tests.
Quality Controls:
Quality Control (QC) is the part of quality assurance which focuses on prevention of product or service defects. It includes inspection, testing, and measurement activities to ensure that products meet required specifications. QC also aims at minimizing errors in production and provides methods for improvement of processes where necessary.
Data Management:
Data management and it's usage in In-Vitro Diagnostics (IVD) quality control market is expected to witness significant growth over the forecast period. The IVD industry has been growing at a rapid pace, owing to technological advancements such as high throughput testing, automation of processes, miniaturization of devices & equipment used for diagnosis along with cost reduction. These factors have led to an increase in demand for data management solutions which are anticipated to drive the market during the forecast period.
Application Insights:
The application segment is bifurcated into clinical chemistry, immunochemistry, hematology, molecular diagnostics coagulation and microbiology. The clinical chemistry segment dominated the global market in terms of revenue share in 2017. This high share is attributable to a large number of tests that are performed using IVD systems for the analysis of samples from patients as well as for reference standards. These include electrolyte analysis (e.g., sodium, potassium), blood gas & electrolyte analyzer (BGL&E) testing such as oxygenation and pH levels along with other analyzers such as complete blood cell count (CBC) and coagulation profile including international normalized ratio (INR).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies and well-established healthcare infrastructure. Moreover, increasing demand for point-of-care (PoC) diagnostics is anticipated to drive growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising government initiatives for quality control services along with growing awareness about IVD in emerging countries such as China and India.
In 2016, The National Health & Family Planning Commission of China launched a national program called “quality first†initiative which includes promoting innovation through research activities.
Growth Factors:
- Increasing demand for quality control in the IVD industry
- Growing number of regulatory requirements for quality control in IVD industry
- Rising incidence of diseases and disorders that require diagnosis and treatment
- Technological advancements in the field of diagnostics
- Growing awareness about the importance of quality control in diagnostic procedures
Scope Of The Report
Report Attributes
Report Details
Report Title
In Vitro Diagnostics (IVD) Quality Control Market Research Report
By Type
Quality Controls, Data Management, Quality Assurance Services
By Application
Clinical Chemistry, Immunochemistry, Hematology, Molecular Diagnostics, Coagulation, Microbiology, Others
By Companies
Siemens Healthcare GmbH, Roche Diagnostics, Abbott, Abbott Laboratories Inc., Bio-Techne, Hologic Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Quidel Corporation, Becton, Dickinson and Company(BD), BioMerieux Inc., Sysmex Corporation, Sero AS, Thermo Fisher Scientific Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global In Vitro Diagnostics (IVD) Quality Control Market Report Segments:
The global In Vitro Diagnostics (IVD) Quality Control market is segmented on the basis of:
Types
Quality Controls, Data Management, Quality Assurance Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Chemistry, Immunochemistry, Hematology, Molecular Diagnostics, Coagulation, Microbiology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens Healthcare GmbH
- Roche Diagnostics
- Abbott
- Abbott Laboratories Inc.
- Bio-Techne
- Hologic Inc.
- Qiagen N.V.
- Bio-Rad Laboratories Inc.
- Quidel Corporation
- Becton
- Dickinson and Company(BD)
- BioMerieux Inc.
- Sysmex Corporation
- Sero AS
- Thermo Fisher Scientific Inc.
Highlights of The In Vitro Diagnostics (IVD) Quality Control Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Quality Controls
- Data Management
- Quality Assurance Services
- By Application:
- Clinical Chemistry
- Immunochemistry
- Hematology
- Molecular Diagnostics
- Coagulation
- Microbiology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In Vitro Diagnostics (IVD) Quality Control Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In Vitro Diagnostics (IVD) Quality Control is a process that ensures the quality of products by identifying and correcting errors in manufacturing.
Some of the key players operating in the in vitro diagnostics (ivd) quality control market are Siemens Healthcare GmbH, Roche Diagnostics, Abbott, Abbott Laboratories Inc., Bio-Techne, Hologic Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Quidel Corporation, Becton, Dickinson and Company(BD), BioMerieux Inc., Sysmex Corporation, Sero AS, Thermo Fisher Scientific Inc..
The in vitro diagnostics (ivd) quality control market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In Vitro Diagnostics (IVD) Quality Control Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 In Vitro Diagnostics (IVD) Quality Control Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 In Vitro Diagnostics (IVD) Quality Control Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the In Vitro Diagnostics (IVD) Quality Control Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global In Vitro Diagnostics (IVD) Quality Control Market Size & Forecast, 2018-2028 4.5.1 In Vitro Diagnostics (IVD) Quality Control Market Size and Y-o-Y Growth 4.5.2 In Vitro Diagnostics (IVD) Quality Control Market Absolute $ Opportunity
Chapter 5 Global In Vitro Diagnostics (IVD) Quality Control Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Type
5.2.1 Quality Controls
5.2.2 Data Management
5.2.3 Quality Assurance Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global In Vitro Diagnostics (IVD) Quality Control Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Applications
6.2.1 Clinical Chemistry
6.2.2 Immunochemistry
6.2.3 Hematology
6.2.4 Molecular Diagnostics
6.2.5 Coagulation
6.2.6 Microbiology
6.2.7 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In Vitro Diagnostics (IVD) Quality Control Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America In Vitro Diagnostics (IVD) Quality Control Analysis and Forecast
9.1 Introduction
9.2 North America In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Type
9.6.1 Quality Controls
9.6.2 Data Management
9.6.3 Quality Assurance Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Applications
9.10.1 Clinical Chemistry
9.10.2 Immunochemistry
9.10.3 Hematology
9.10.4 Molecular Diagnostics
9.10.5 Coagulation
9.10.6 Microbiology
9.10.7 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe In Vitro Diagnostics (IVD) Quality Control Analysis and Forecast
10.1 Introduction
10.2 Europe In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Type
10.6.1 Quality Controls
10.6.2 Data Management
10.6.3 Quality Assurance Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Applications
10.10.1 Clinical Chemistry
10.10.2 Immunochemistry
10.10.3 Hematology
10.10.4 Molecular Diagnostics
10.10.5 Coagulation
10.10.6 Microbiology
10.10.7 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific In Vitro Diagnostics (IVD) Quality Control Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Type
11.6.1 Quality Controls
11.6.2 Data Management
11.6.3 Quality Assurance Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Applications
11.10.1 Clinical Chemistry
11.10.2 Immunochemistry
11.10.3 Hematology
11.10.4 Molecular Diagnostics
11.10.5 Coagulation
11.10.6 Microbiology
11.10.7 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America In Vitro Diagnostics (IVD) Quality Control Analysis and Forecast
12.1 Introduction
12.2 Latin America In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Type
12.6.1 Quality Controls
12.6.2 Data Management
12.6.3 Quality Assurance Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Applications
12.10.1 Clinical Chemistry
12.10.2 Immunochemistry
12.10.3 Hematology
12.10.4 Molecular Diagnostics
12.10.5 Coagulation
12.10.6 Microbiology
12.10.7 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) In Vitro Diagnostics (IVD) Quality Control Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Type
13.6.1 Quality Controls
13.6.2 Data Management
13.6.3 Quality Assurance Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) In Vitro Diagnostics (IVD) Quality Control Market Size Forecast by Applications
13.10.1 Clinical Chemistry
13.10.2 Immunochemistry
13.10.3 Hematology
13.10.4 Molecular Diagnostics
13.10.5 Coagulation
13.10.6 Microbiology
13.10.7 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In Vitro Diagnostics (IVD) Quality Control Market: Competitive Dashboard
14.2 Global In Vitro Diagnostics (IVD) Quality Control Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens Healthcare GmbH
14.3.2 Roche Diagnostics
14.3.3 Abbott
14.3.4 Abbott Laboratories Inc.
14.3.5 Bio-Techne
14.3.6 Hologic Inc.
14.3.7 Qiagen N.V.
14.3.8 Bio-Rad Laboratories Inc.
14.3.9 Quidel Corporation
14.3.10 Becton
14.3.11 Dickinson and Company(BD)
14.3.12 BioMerieux Inc.
14.3.13 Sysmex Corporation
14.3.14 Sero AS
14.3.15 Thermo Fisher Scientific Inc.